Vaxess Technologies announced it raised $35 Million in an amended filing from an offering of $35 Million

Company

Location

About

Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. We are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.